Matches in Wikidata for { <http://www.wikidata.org/entity/Q86255716> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q86255716 description "clinical trial" @default.
- Q86255716 description "ensayu clínicu" @default.
- Q86255716 description "klinisch onderzoek" @default.
- Q86255716 description "клінічне випробування" @default.
- Q86255716 name "Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body" @default.
- Q86255716 name "Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body" @default.
- Q86255716 type Item @default.
- Q86255716 label "Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body" @default.
- Q86255716 label "Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body" @default.
- Q86255716 prefLabel "Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body" @default.
- Q86255716 prefLabel "Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body" @default.
- Q86255716 P1050 Q86255716-9D9244C6-657E-459C-BA8F-B41CE8C79282 @default.
- Q86255716 P1132 Q86255716-D970A759-2C95-42DE-9950-10D929F5AD71 @default.
- Q86255716 P1476 Q86255716-C04CF90D-3E46-4FFA-B6ED-336E26DC4297 @default.
- Q86255716 P2899 Q86255716-29EF25A6-3A28-420A-848A-0769A30A3891 @default.
- Q86255716 P3098 Q86255716-B44050BD-2F1F-47A8-A850-C55722C4C98A @default.
- Q86255716 P31 Q86255716-FE6A4242-9A66-4905-87B8-90491B76CB77 @default.
- Q86255716 P4844 Q86255716-3C0F8AE7-73EB-4A33-9369-93F3CB0806EA @default.
- Q86255716 P4844 Q86255716-6C66841E-0E1B-4C42-968E-F38123B1EA82 @default.
- Q86255716 P4844 Q86255716-936ABBA4-DFA8-4E18-975D-8E09209441EC @default.
- Q86255716 P4844 Q86255716-9DDB03D3-21FB-449A-9797-B5E04997399E @default.
- Q86255716 P4844 Q86255716-C71DF08B-F5F8-4456-882E-869E7C177D49 @default.
- Q86255716 P4844 Q86255716-DCE72C73-C468-47FC-9F38-04D64BA1B677 @default.
- Q86255716 P580 Q86255716-0CB91612-6339-4BF7-BB0F-1693CCE1C8C8 @default.
- Q86255716 P582 Q86255716-93B8D24A-EAF5-42FA-A71E-020611012B5C @default.
- Q86255716 P6099 Q86255716-4240F4D0-E453-469A-9FDF-DC4EFC891DB4 @default.
- Q86255716 P767 Q86255716-D0C9EC2A-47FC-4339-ACBC-AA4BA0265F8B @default.
- Q86255716 P8363 Q86255716-16460F73-9C11-4649-A68B-7C92FFD3AFC1 @default.
- Q86255716 P1050 Q356033 @default.
- Q86255716 P1132 "+314" @default.
- Q86255716 P1476 "A Phase III Study of Consolidative Radiotherapy in Patients With Oligometastatic HER2 Negative Esophageal and Gastric Adenocarcinoma (EGA)" @default.
- Q86255716 P2899 "+18" @default.
- Q86255716 P3098 "NCT04248452" @default.
- Q86255716 P31 Q30612 @default.
- Q86255716 P4844 Q127060 @default.
- Q86255716 P4844 Q192464 @default.
- Q86255716 P4844 Q238512 @default.
- Q86255716 P4844 Q420207 @default.
- Q86255716 P4844 Q422327 @default.
- Q86255716 P4844 Q483745 @default.
- Q86255716 P580 "2020-02-06T00:00:00Z" @default.
- Q86255716 P582 "2023-12-31T00:00:00Z" @default.
- Q86255716 P6099 Q42824827 @default.
- Q86255716 P767 Q664846 @default.
- Q86255716 P8363 Q78089383 @default.